Erythropoiesis-stimulating agents for myelodysplastic syndromes

Abstract:

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the clinical efficacy and safety of using any ESA for the treatment of anemia related to MDS in adult patients in terms of overall survival, quality of life, hematologic response and transfusional requirement?

Año de publicación:

2016

Keywords:

Fuente:

scopus